WebCisplatin (10 mg)is an antineoplastic agent. It works by stopping cancer cells from growing and reproducing. Important safety information: Cisplatin may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. WebUse in Cancer. Cisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is used alone in patients with advanced cancer that cannot be treated with …

Cisplatin-Ribosepharm Χρήσεις, Δοσολογία, Παρενέργειες

WebCisplatin is administered through a vein (intravenously or IV) as an infusion. There is no pill form of cisplatin. Cisplatin is an irritant. An irritant is a chemical that can cause inflammation of the vein through which it is given. If cisplatin escapes from the vein it can cause tissue damage. WebDocetaxel Accord in combination with cisplatin and 5-fluorouracil is indicated for the treatment of patients with metastatic gastric adenocarcinoma, including adenocarcinoma … irish life managed funds

HIGHLIGHTS OF PRESCRIBING INFORMATION - Food and …

WebJun 22, 2024 · جرعات وطرق الاستعمال. Cisplatino Kampar جرعات وطرق الاستعمال. Metastatic ovarian cancer: As monotherapy: 100 mg/m2 per cycle, given as a single dose infused in 0.9% sodium chloride or glucose once every 4 wk. For combination therapy with cyclophosphamide: 75-100 mg/m2 on day 1 of every 4-wk cycle. WebPharmacology: Cisplatin Ribosepharm is an antineoplastic agent with biochemical properties similar to those of biofunctional alkylating agents. Although not yet clearly … WebThis exposure to cisplatin results in a range of toxicities . In addition, circulating …. Prevention of chemotherapy-induced nausea and vomiting in adults. …remains necessary, at least in patients receiving cisplatin -based chemotherapy. This was illustrated by a randomized trial in which patients receiving cisplatin chemotherapy were ... port alberni gis mapping